Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

Keytruda monotherapy in 2L-HCC misses primary endpoints in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 735
Posts 111,811
Boards Moderated 18
Alias Born 09/05/02
160x600 placeholder
Merck Announces $3M Commitment to Address Critical Maternal Health Needs During COVID-19 Pandemic Business Wire - 4/9/2020 8:00:00 AM
Merck Gets FDA Priority Review for Second Application for Keytruda Based on Biomarker Dow Jones News - 4/7/2020 7:57:00 AM
Merck Receives Priority Review from FDA for Second Application for KEYTRUDA® (pembrolizumab) Based on Biomarker, Regardless ... Business Wire - 4/7/2020 6:45:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/6/2020 4:49:02 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/6/2020 4:49:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:50:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:44:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:38:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:35:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:34:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:30:41 PM
Merck's Keytruda Hits a Main Endpoint in Colorectal Cancer Study Dow Jones News - 4/2/2020 7:42:00 AM
Merck Announces KEYTRUDA® (pembrolizumab) Significantly Improved Progression-Free Survival as First-Line Treatment for Advan... Business Wire - 4/2/2020 6:45:00 AM
Merck to Hold First-Quarter 2020 Sales and Earnings Conference Call on April 28 Business Wire - 4/2/2020 6:30:00 AM
Medical Professionals Across Merck & Co., Inc., Pfizer Inc., & Eli Lilly & Company Activate to Support Health Systems, First ... Business Wire - 4/1/2020 4:00:00 PM
Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or ... Business Wire - 3/28/2020 10:00:00 AM
Merck to Donate 300,000 Masks to New Jersey for COVID-19 Emergency Response Business Wire - 3/25/2020 5:00:00 PM
Merck Donates Half a Million Protective Masks to New York City Dow Jones News - 3/23/2020 6:32:00 AM
Merck Donates a Half a Million Masks to Support COVID-19 Emergency Response in New York City Business Wire - 3/22/2020 11:52:00 AM
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer Business Wire - 3/20/2020 5:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/18/2020 5:26:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/18/2020 5:25:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/18/2020 5:18:58 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/18/2020 5:17:29 PM
Merck Announces Top-Line Results from Phase 3 Trials Evaluating Gefapixant, an Investigational Treatment for Refractory or Un... Business Wire - 3/17/2020 6:45:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist